Philips Respironics recalls Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC, Garbin, Garbin Plus Trilogy 100, Trilogy 200, Garbin, Ga…
- Recall date
- January 18, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1065-2016
- FDA classification
- Class II
- Brand / firm
- Philips Respironics
- Sold / distributed
- Nationwide Distribution including Puerto Rico and Internationally to the US Virgin Islands.
Why it was recalled
Software Issue
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC, Garbin, Garbin Plus Trilogy 100, Trilogy 200, Garbin, Garbin plus provides continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Get recall alerts
Free email alert whenever Philips Respironics has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Philips Respironics